ACTU
insider transactionsACTUATE THERAPEUTICS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-280.0K
0 buy · 280.0K sell
Net value · 365d
-$1.6M
$0 in · $1.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 280.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
15.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
15.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own New
-
Grant·A
Director
$0
15.0K sh
Own New
-
Grant·A
Director, 10% Owner
$0
15.0K sh
Own New
-
Grant·A
Daniel M Schmitt KEY
President, CEO and Director
$0
237.0K sh
Own New
-
Grant·A
Chief Operating Officer
$0
105.0K sh
Own New
-
Grant·A
Paul J Lytle KEY
Chief Financial Officer
$0
105.0K sh
Own New
-
Exercise·M
Daniel M Schmitt KEY
President, CEO and Director
$0
272.1K sh
Own +27205500%
-
Other·F
Daniel M Schmitt KEY
President, CEO and Director
$527.7K
121.9K sh · $4.33
Own -45%
-
Exercise·M
Daniel M Schmitt KEY
President, CEO and Director
$0
272.1K sh
Own New
-
Sell·S
Todd S Thomson / Kairos Venture Partners II, L.P.
Director, 10% Owner
$1.6M
280.0K sh · $5.80
Own -24%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Dan Zabrowski | Grant A | 15.0K | $0 |
| May 21, 2026 | Todd S Thomson | Grant A | 15.0K | $0 |
| May 21, 2026 | Roger Sawhney | Grant A | 15.0K | $0 |
| May 21, 2026 | Amy L Ronneberg | Grant A | 15.0K | $0 |
| May 21, 2026 | Jason A Keyes | Grant A | 15.0K | $0 |
| May 21, 2026 | Martin H. Huber Jr. | Grant A | 15.0K | $0 |
| May 21, 2026 | Aaron G.L. Fletcher | Grant A | 15.0K | $0 |
| Apr 1, 2026 | Daniel M Schmitt KEY | Grant A | 237.0K | $0 |
| Apr 1, 2026 | Andrew Paul Mazar | Grant A | 105.0K | $0 |
| Apr 1, 2026 | Paul J Lytle KEY | Grant A | 105.0K | $0 |
| Feb 13, 2026 | Daniel M Schmitt KEY | Exercise M | 272.1K | $0 |
| Feb 13, 2026 | Daniel M Schmitt KEY | Other F | 121.9K | $527.7K |
| Feb 13, 2026 | Daniel M Schmitt KEY | Exercise M | 272.1K | $0 |
| Jan 5, 2026 | Todd S Thomson / Kairos Venture Partners II, L.P. | Sell S | 280.0K | $1.6M |
About ACTU insider trading
This page tracks insider transactions for ACTUATE THERAPEUTICS, INC. (ACTU) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.